Global Flu RNA Vaccines Market Research Report 2024(Status and Outlook)
Report Overview:
Flu RNA Vaccines, commonly known as flu vaccines, are designed to protect against the influenza virus. The influenza virus can cause respiratory illnesses ranging from mild to severe, and vaccination is an effective way to prevent or reduce the severity of flu infections.
Flu RNA Vaccines are an important public health measure to prevent the spread of the influenza virus and reduce the risk of severe illness, hospitalization, and death associated with the flu.
The Global Flu RNA Vaccines Market Size was estimated at USD 992.06 million in 2023 and is projected to reach USD 1719.50 million by 2029, exhibiting a CAGR of 9.60% during the forecast period.
This report provides a deep insight into the global Flu RNA Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Flu RNA Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Flu RNA Vaccines market in any manner.
Global Flu RNA Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Sanofi Pasteur Inc.
AstraZeneca
CSL Ltd.
Abbott
GlaxoSmithKline Plc.
Serum Institute of India Pvt. Ltd.
Pfizer
BioNTech
F.Hoffman La Roche Ltd
Novartis
Sinnovac Biotech Ltd
Moderna Therapeutics
CureVac
Market Segmentation (by Type)
Non-Replicating mRNA
In Vivo Self-Replicating mRNA
In Vitro Dendritic Cell Non-Replicating mRNA Vaccine
Others
Market Segmentation (by Application)
Hospitals
Vaccination Center
Specialized Clinics
Hospital Pharmacy
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Flu RNA Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Flu RNA Vaccines, commonly known as flu vaccines, are designed to protect against the influenza virus. The influenza virus can cause respiratory illnesses ranging from mild to severe, and vaccination is an effective way to prevent or reduce the severity of flu infections.
Flu RNA Vaccines are an important public health measure to prevent the spread of the influenza virus and reduce the risk of severe illness, hospitalization, and death associated with the flu.
The Global Flu RNA Vaccines Market Size was estimated at USD 992.06 million in 2023 and is projected to reach USD 1719.50 million by 2029, exhibiting a CAGR of 9.60% during the forecast period.
This report provides a deep insight into the global Flu RNA Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Flu RNA Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Flu RNA Vaccines market in any manner.
Global Flu RNA Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Sanofi Pasteur Inc.
AstraZeneca
CSL Ltd.
Abbott
GlaxoSmithKline Plc.
Serum Institute of India Pvt. Ltd.
Pfizer
BioNTech
F.Hoffman La Roche Ltd
Novartis
Sinnovac Biotech Ltd
Moderna Therapeutics
CureVac
Market Segmentation (by Type)
Non-Replicating mRNA
In Vivo Self-Replicating mRNA
In Vitro Dendritic Cell Non-Replicating mRNA Vaccine
Others
Market Segmentation (by Application)
Hospitals
Vaccination Center
Specialized Clinics
Hospital Pharmacy
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Flu RNA Vaccines Market
- Overview of the regional outlook of the Flu RNA Vaccines Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Flu RNA Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Flu RNA Vaccines
1.2 Key Market Segments
1.2.1 Flu RNA Vaccines Segment by Type
1.2.2 Flu RNA Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 FLU RNA VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Flu RNA Vaccines Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Flu RNA Vaccines Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 FLU RNA VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Global Flu RNA Vaccines Sales by Manufacturers (2019-2024)
3.2 Global Flu RNA Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.3 Flu RNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Flu RNA Vaccines Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Flu RNA Vaccines Sales Sites, Area Served, Product Type
3.6 Flu RNA Vaccines Market Competitive Situation and Trends
3.6.1 Flu RNA Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Flu RNA Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 FLU RNA VACCINES INDUSTRY CHAIN ANALYSIS
4.1 Flu RNA Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF FLU RNA VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 FLU RNA VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Flu RNA Vaccines Sales Market Share by Type (2019-2024)
6.3 Global Flu RNA Vaccines Market Size Market Share by Type (2019-2024)
6.4 Global Flu RNA Vaccines Price by Type (2019-2024)
7 FLU RNA VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Flu RNA Vaccines Market Sales by Application (2019-2024)
7.3 Global Flu RNA Vaccines Market Size (M USD) by Application (2019-2024)
7.4 Global Flu RNA Vaccines Sales Growth Rate by Application (2019-2024)
8 FLU RNA VACCINES MARKET SEGMENTATION BY REGION
8.1 Global Flu RNA Vaccines Sales by Region
8.1.1 Global Flu RNA Vaccines Sales by Region
8.1.2 Global Flu RNA Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Flu RNA Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Flu RNA Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Flu RNA Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Flu RNA Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Flu RNA Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Sanofi Pasteur Inc.
9.1.1 Sanofi Pasteur Inc. Flu RNA Vaccines Basic Information
9.1.2 Sanofi Pasteur Inc. Flu RNA Vaccines Product Overview
9.1.3 Sanofi Pasteur Inc. Flu RNA Vaccines Product Market Performance
9.1.4 Sanofi Pasteur Inc. Business Overview
9.1.5 Sanofi Pasteur Inc. Flu RNA Vaccines SWOT Analysis
9.1.6 Sanofi Pasteur Inc. Recent Developments
9.2 AstraZeneca
9.2.1 AstraZeneca Flu RNA Vaccines Basic Information
9.2.2 AstraZeneca Flu RNA Vaccines Product Overview
9.2.3 AstraZeneca Flu RNA Vaccines Product Market Performance
9.2.4 AstraZeneca Business Overview
9.2.5 AstraZeneca Flu RNA Vaccines SWOT Analysis
9.2.6 AstraZeneca Recent Developments
9.3 CSL Ltd.
9.3.1 CSL Ltd. Flu RNA Vaccines Basic Information
9.3.2 CSL Ltd. Flu RNA Vaccines Product Overview
9.3.3 CSL Ltd. Flu RNA Vaccines Product Market Performance
9.3.4 CSL Ltd. Flu RNA Vaccines SWOT Analysis
9.3.5 CSL Ltd. Business Overview
9.3.6 CSL Ltd. Recent Developments
9.4 Abbott
9.4.1 Abbott Flu RNA Vaccines Basic Information
9.4.2 Abbott Flu RNA Vaccines Product Overview
9.4.3 Abbott Flu RNA Vaccines Product Market Performance
9.4.4 Abbott Business Overview
9.4.5 Abbott Recent Developments
9.5 GlaxoSmithKline Plc.
9.5.1 GlaxoSmithKline Plc. Flu RNA Vaccines Basic Information
9.5.2 GlaxoSmithKline Plc. Flu RNA Vaccines Product Overview
9.5.3 GlaxoSmithKline Plc. Flu RNA Vaccines Product Market Performance
9.5.4 GlaxoSmithKline Plc. Business Overview
9.5.5 GlaxoSmithKline Plc. Recent Developments
9.6 Serum Institute of India Pvt. Ltd.
9.6.1 Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Basic Information
9.6.2 Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Product Overview
9.6.3 Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Product Market Performance
9.6.4 Serum Institute of India Pvt. Ltd. Business Overview
9.6.5 Serum Institute of India Pvt. Ltd. Recent Developments
9.7 Pfizer
9.7.1 Pfizer Flu RNA Vaccines Basic Information
9.7.2 Pfizer Flu RNA Vaccines Product Overview
9.7.3 Pfizer Flu RNA Vaccines Product Market Performance
9.7.4 Pfizer Business Overview
9.7.5 Pfizer Recent Developments
9.8 BioNTech
9.8.1 BioNTech Flu RNA Vaccines Basic Information
9.8.2 BioNTech Flu RNA Vaccines Product Overview
9.8.3 BioNTech Flu RNA Vaccines Product Market Performance
9.8.4 BioNTech Business Overview
9.8.5 BioNTech Recent Developments
9.9 F.Hoffman La Roche Ltd
9.9.1 F.Hoffman La Roche Ltd Flu RNA Vaccines Basic Information
9.9.2 F.Hoffman La Roche Ltd Flu RNA Vaccines Product Overview
9.9.3 F.Hoffman La Roche Ltd Flu RNA Vaccines Product Market Performance
9.9.4 F.Hoffman La Roche Ltd Business Overview
9.9.5 F.Hoffman La Roche Ltd Recent Developments
9.10 Novartis
9.10.1 Novartis Flu RNA Vaccines Basic Information
9.10.2 Novartis Flu RNA Vaccines Product Overview
9.10.3 Novartis Flu RNA Vaccines Product Market Performance
9.10.4 Novartis Business Overview
9.10.5 Novartis Recent Developments
9.11 Sinnovac Biotech Ltd
9.11.1 Sinnovac Biotech Ltd Flu RNA Vaccines Basic Information
9.11.2 Sinnovac Biotech Ltd Flu RNA Vaccines Product Overview
9.11.3 Sinnovac Biotech Ltd Flu RNA Vaccines Product Market Performance
9.11.4 Sinnovac Biotech Ltd Business Overview
9.11.5 Sinnovac Biotech Ltd Recent Developments
9.12 Moderna Therapeutics
9.12.1 Moderna Therapeutics Flu RNA Vaccines Basic Information
9.12.2 Moderna Therapeutics Flu RNA Vaccines Product Overview
9.12.3 Moderna Therapeutics Flu RNA Vaccines Product Market Performance
9.12.4 Moderna Therapeutics Business Overview
9.12.5 Moderna Therapeutics Recent Developments
9.13 CureVac
9.13.1 CureVac Flu RNA Vaccines Basic Information
9.13.2 CureVac Flu RNA Vaccines Product Overview
9.13.3 CureVac Flu RNA Vaccines Product Market Performance
9.13.4 CureVac Business Overview
9.13.5 CureVac Recent Developments
10 FLU RNA VACCINES MARKET FORECAST BY REGION
10.1 Global Flu RNA Vaccines Market Size Forecast
10.2 Global Flu RNA Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Flu RNA Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Flu RNA Vaccines Market Size Forecast by Region
10.2.4 South America Flu RNA Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Flu RNA Vaccines by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Flu RNA Vaccines Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Flu RNA Vaccines by Type (2025-2030)
11.1.2 Global Flu RNA Vaccines Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Flu RNA Vaccines by Type (2025-2030)
11.2 Global Flu RNA Vaccines Market Forecast by Application (2025-2030)
11.2.1 Global Flu RNA Vaccines Sales (K Units) Forecast by Application
11.2.2 Global Flu RNA Vaccines Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Flu RNA Vaccines
1.2 Key Market Segments
1.2.1 Flu RNA Vaccines Segment by Type
1.2.2 Flu RNA Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 FLU RNA VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Flu RNA Vaccines Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Flu RNA Vaccines Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 FLU RNA VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Global Flu RNA Vaccines Sales by Manufacturers (2019-2024)
3.2 Global Flu RNA Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.3 Flu RNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Flu RNA Vaccines Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Flu RNA Vaccines Sales Sites, Area Served, Product Type
3.6 Flu RNA Vaccines Market Competitive Situation and Trends
3.6.1 Flu RNA Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Flu RNA Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 FLU RNA VACCINES INDUSTRY CHAIN ANALYSIS
4.1 Flu RNA Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF FLU RNA VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 FLU RNA VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Flu RNA Vaccines Sales Market Share by Type (2019-2024)
6.3 Global Flu RNA Vaccines Market Size Market Share by Type (2019-2024)
6.4 Global Flu RNA Vaccines Price by Type (2019-2024)
7 FLU RNA VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Flu RNA Vaccines Market Sales by Application (2019-2024)
7.3 Global Flu RNA Vaccines Market Size (M USD) by Application (2019-2024)
7.4 Global Flu RNA Vaccines Sales Growth Rate by Application (2019-2024)
8 FLU RNA VACCINES MARKET SEGMENTATION BY REGION
8.1 Global Flu RNA Vaccines Sales by Region
8.1.1 Global Flu RNA Vaccines Sales by Region
8.1.2 Global Flu RNA Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Flu RNA Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Flu RNA Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Flu RNA Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Flu RNA Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Flu RNA Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Sanofi Pasteur Inc.
9.1.1 Sanofi Pasteur Inc. Flu RNA Vaccines Basic Information
9.1.2 Sanofi Pasteur Inc. Flu RNA Vaccines Product Overview
9.1.3 Sanofi Pasteur Inc. Flu RNA Vaccines Product Market Performance
9.1.4 Sanofi Pasteur Inc. Business Overview
9.1.5 Sanofi Pasteur Inc. Flu RNA Vaccines SWOT Analysis
9.1.6 Sanofi Pasteur Inc. Recent Developments
9.2 AstraZeneca
9.2.1 AstraZeneca Flu RNA Vaccines Basic Information
9.2.2 AstraZeneca Flu RNA Vaccines Product Overview
9.2.3 AstraZeneca Flu RNA Vaccines Product Market Performance
9.2.4 AstraZeneca Business Overview
9.2.5 AstraZeneca Flu RNA Vaccines SWOT Analysis
9.2.6 AstraZeneca Recent Developments
9.3 CSL Ltd.
9.3.1 CSL Ltd. Flu RNA Vaccines Basic Information
9.3.2 CSL Ltd. Flu RNA Vaccines Product Overview
9.3.3 CSL Ltd. Flu RNA Vaccines Product Market Performance
9.3.4 CSL Ltd. Flu RNA Vaccines SWOT Analysis
9.3.5 CSL Ltd. Business Overview
9.3.6 CSL Ltd. Recent Developments
9.4 Abbott
9.4.1 Abbott Flu RNA Vaccines Basic Information
9.4.2 Abbott Flu RNA Vaccines Product Overview
9.4.3 Abbott Flu RNA Vaccines Product Market Performance
9.4.4 Abbott Business Overview
9.4.5 Abbott Recent Developments
9.5 GlaxoSmithKline Plc.
9.5.1 GlaxoSmithKline Plc. Flu RNA Vaccines Basic Information
9.5.2 GlaxoSmithKline Plc. Flu RNA Vaccines Product Overview
9.5.3 GlaxoSmithKline Plc. Flu RNA Vaccines Product Market Performance
9.5.4 GlaxoSmithKline Plc. Business Overview
9.5.5 GlaxoSmithKline Plc. Recent Developments
9.6 Serum Institute of India Pvt. Ltd.
9.6.1 Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Basic Information
9.6.2 Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Product Overview
9.6.3 Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Product Market Performance
9.6.4 Serum Institute of India Pvt. Ltd. Business Overview
9.6.5 Serum Institute of India Pvt. Ltd. Recent Developments
9.7 Pfizer
9.7.1 Pfizer Flu RNA Vaccines Basic Information
9.7.2 Pfizer Flu RNA Vaccines Product Overview
9.7.3 Pfizer Flu RNA Vaccines Product Market Performance
9.7.4 Pfizer Business Overview
9.7.5 Pfizer Recent Developments
9.8 BioNTech
9.8.1 BioNTech Flu RNA Vaccines Basic Information
9.8.2 BioNTech Flu RNA Vaccines Product Overview
9.8.3 BioNTech Flu RNA Vaccines Product Market Performance
9.8.4 BioNTech Business Overview
9.8.5 BioNTech Recent Developments
9.9 F.Hoffman La Roche Ltd
9.9.1 F.Hoffman La Roche Ltd Flu RNA Vaccines Basic Information
9.9.2 F.Hoffman La Roche Ltd Flu RNA Vaccines Product Overview
9.9.3 F.Hoffman La Roche Ltd Flu RNA Vaccines Product Market Performance
9.9.4 F.Hoffman La Roche Ltd Business Overview
9.9.5 F.Hoffman La Roche Ltd Recent Developments
9.10 Novartis
9.10.1 Novartis Flu RNA Vaccines Basic Information
9.10.2 Novartis Flu RNA Vaccines Product Overview
9.10.3 Novartis Flu RNA Vaccines Product Market Performance
9.10.4 Novartis Business Overview
9.10.5 Novartis Recent Developments
9.11 Sinnovac Biotech Ltd
9.11.1 Sinnovac Biotech Ltd Flu RNA Vaccines Basic Information
9.11.2 Sinnovac Biotech Ltd Flu RNA Vaccines Product Overview
9.11.3 Sinnovac Biotech Ltd Flu RNA Vaccines Product Market Performance
9.11.4 Sinnovac Biotech Ltd Business Overview
9.11.5 Sinnovac Biotech Ltd Recent Developments
9.12 Moderna Therapeutics
9.12.1 Moderna Therapeutics Flu RNA Vaccines Basic Information
9.12.2 Moderna Therapeutics Flu RNA Vaccines Product Overview
9.12.3 Moderna Therapeutics Flu RNA Vaccines Product Market Performance
9.12.4 Moderna Therapeutics Business Overview
9.12.5 Moderna Therapeutics Recent Developments
9.13 CureVac
9.13.1 CureVac Flu RNA Vaccines Basic Information
9.13.2 CureVac Flu RNA Vaccines Product Overview
9.13.3 CureVac Flu RNA Vaccines Product Market Performance
9.13.4 CureVac Business Overview
9.13.5 CureVac Recent Developments
10 FLU RNA VACCINES MARKET FORECAST BY REGION
10.1 Global Flu RNA Vaccines Market Size Forecast
10.2 Global Flu RNA Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Flu RNA Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Flu RNA Vaccines Market Size Forecast by Region
10.2.4 South America Flu RNA Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Flu RNA Vaccines by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Flu RNA Vaccines Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Flu RNA Vaccines by Type (2025-2030)
11.1.2 Global Flu RNA Vaccines Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Flu RNA Vaccines by Type (2025-2030)
11.2 Global Flu RNA Vaccines Market Forecast by Application (2025-2030)
11.2.1 Global Flu RNA Vaccines Sales (K Units) Forecast by Application
11.2.2 Global Flu RNA Vaccines Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Flu RNA Vaccines Market Size Comparison by Region (M USD)
Table 5. Global Flu RNA Vaccines Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Flu RNA Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Flu RNA Vaccines Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Flu RNA Vaccines Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flu RNA Vaccines as of 2022)
Table 10. Global Market Flu RNA Vaccines Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Flu RNA Vaccines Sales Sites and Area Served
Table 12. Manufacturers Flu RNA Vaccines Product Type
Table 13. Global Flu RNA Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Flu RNA Vaccines
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Flu RNA Vaccines Market Challenges
Table 22. Global Flu RNA Vaccines Sales by Type (K Units)
Table 23. Global Flu RNA Vaccines Market Size by Type (M USD)
Table 24. Global Flu RNA Vaccines Sales (K Units) by Type (2019-2024)
Table 25. Global Flu RNA Vaccines Sales Market Share by Type (2019-2024)
Table 26. Global Flu RNA Vaccines Market Size (M USD) by Type (2019-2024)
Table 27. Global Flu RNA Vaccines Market Size Share by Type (2019-2024)
Table 28. Global Flu RNA Vaccines Price (USD/Unit) by Type (2019-2024)
Table 29. Global Flu RNA Vaccines Sales (K Units) by Application
Table 30. Global Flu RNA Vaccines Market Size by Application
Table 31. Global Flu RNA Vaccines Sales by Application (2019-2024) & (K Units)
Table 32. Global Flu RNA Vaccines Sales Market Share by Application (2019-2024)
Table 33. Global Flu RNA Vaccines Sales by Application (2019-2024) & (M USD)
Table 34. Global Flu RNA Vaccines Market Share by Application (2019-2024)
Table 35. Global Flu RNA Vaccines Sales Growth Rate by Application (2019-2024)
Table 36. Global Flu RNA Vaccines Sales by Region (2019-2024) & (K Units)
Table 37. Global Flu RNA Vaccines Sales Market Share by Region (2019-2024)
Table 38. North America Flu RNA Vaccines Sales by Country (2019-2024) & (K Units)
Table 39. Europe Flu RNA Vaccines Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Flu RNA Vaccines Sales by Region (2019-2024) & (K Units)
Table 41. South America Flu RNA Vaccines Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Flu RNA Vaccines Sales by Region (2019-2024) & (K Units)
Table 43. Sanofi Pasteur Inc. Flu RNA Vaccines Basic Information
Table 44. Sanofi Pasteur Inc. Flu RNA Vaccines Product Overview
Table 45. Sanofi Pasteur Inc. Flu RNA Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Sanofi Pasteur Inc. Business Overview
Table 47. Sanofi Pasteur Inc. Flu RNA Vaccines SWOT Analysis
Table 48. Sanofi Pasteur Inc. Recent Developments
Table 49. AstraZeneca Flu RNA Vaccines Basic Information
Table 50. AstraZeneca Flu RNA Vaccines Product Overview
Table 51. AstraZeneca Flu RNA Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Flu RNA Vaccines SWOT Analysis
Table 54. AstraZeneca Recent Developments
Table 55. CSL Ltd. Flu RNA Vaccines Basic Information
Table 56. CSL Ltd. Flu RNA Vaccines Product Overview
Table 57. CSL Ltd. Flu RNA Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. CSL Ltd. Flu RNA Vaccines SWOT Analysis
Table 59. CSL Ltd. Business Overview
Table 60. CSL Ltd. Recent Developments
Table 61. Abbott Flu RNA Vaccines Basic Information
Table 62. Abbott Flu RNA Vaccines Product Overview
Table 63. Abbott Flu RNA Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Abbott Business Overview
Table 65. Abbott Recent Developments
Table 66. GlaxoSmithKline Plc. Flu RNA Vaccines Basic Information
Table 67. GlaxoSmithKline Plc. Flu RNA Vaccines Product Overview
Table 68. GlaxoSmithKline Plc. Flu RNA Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. GlaxoSmithKline Plc. Business Overview
Table 70. GlaxoSmithKline Plc. Recent Developments
Table 71. Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Basic Information
Table 72. Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Product Overview
Table 73. Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Serum Institute of India Pvt. Ltd. Business Overview
Table 75. Serum Institute of India Pvt. Ltd. Recent Developments
Table 76. Pfizer Flu RNA Vaccines Basic Information
Table 77. Pfizer Flu RNA Vaccines Product Overview
Table 78. Pfizer Flu RNA Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Pfizer Business Overview
Table 80. Pfizer Recent Developments
Table 81. BioNTech Flu RNA Vaccines Basic Information
Table 82. BioNTech Flu RNA Vaccines Product Overview
Table 83. BioNTech Flu RNA Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. BioNTech Business Overview
Table 85. BioNTech Recent Developments
Table 86. F.Hoffman La Roche Ltd Flu RNA Vaccines Basic Information
Table 87. F.Hoffman La Roche Ltd Flu RNA Vaccines Product Overview
Table 88. F.Hoffman La Roche Ltd Flu RNA Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. F.Hoffman La Roche Ltd Business Overview
Table 90. F.Hoffman La Roche Ltd Recent Developments
Table 91. Novartis Flu RNA Vaccines Basic Information
Table 92. Novartis Flu RNA Vaccines Product Overview
Table 93. Novartis Flu RNA Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Novartis Business Overview
Table 95. Novartis Recent Developments
Table 96. Sinnovac Biotech Ltd Flu RNA Vaccines Basic Information
Table 97. Sinnovac Biotech Ltd Flu RNA Vaccines Product Overview
Table 98. Sinnovac Biotech Ltd Flu RNA Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Sinnovac Biotech Ltd Business Overview
Table 100. Sinnovac Biotech Ltd Recent Developments
Table 101. Moderna Therapeutics Flu RNA Vaccines Basic Information
Table 102. Moderna Therapeutics Flu RNA Vaccines Product Overview
Table 103. Moderna Therapeutics Flu RNA Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Moderna Therapeutics Business Overview
Table 105. Moderna Therapeutics Recent Developments
Table 106. CureVac Flu RNA Vaccines Basic Information
Table 107. CureVac Flu RNA Vaccines Product Overview
Table 108. CureVac Flu RNA Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. CureVac Business Overview
Table 110. CureVac Recent Developments
Table 111. Global Flu RNA Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Flu RNA Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Flu RNA Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Flu RNA Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Flu RNA Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Flu RNA Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Flu RNA Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Flu RNA Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Flu RNA Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Flu RNA Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Flu RNA Vaccines Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Flu RNA Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Flu RNA Vaccines Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Flu RNA Vaccines Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Flu RNA Vaccines Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Flu RNA Vaccines Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Flu RNA Vaccines Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Flu RNA Vaccines Market Size Comparison by Region (M USD)
Table 5. Global Flu RNA Vaccines Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Flu RNA Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Flu RNA Vaccines Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Flu RNA Vaccines Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flu RNA Vaccines as of 2022)
Table 10. Global Market Flu RNA Vaccines Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Flu RNA Vaccines Sales Sites and Area Served
Table 12. Manufacturers Flu RNA Vaccines Product Type
Table 13. Global Flu RNA Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Flu RNA Vaccines
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Flu RNA Vaccines Market Challenges
Table 22. Global Flu RNA Vaccines Sales by Type (K Units)
Table 23. Global Flu RNA Vaccines Market Size by Type (M USD)
Table 24. Global Flu RNA Vaccines Sales (K Units) by Type (2019-2024)
Table 25. Global Flu RNA Vaccines Sales Market Share by Type (2019-2024)
Table 26. Global Flu RNA Vaccines Market Size (M USD) by Type (2019-2024)
Table 27. Global Flu RNA Vaccines Market Size Share by Type (2019-2024)
Table 28. Global Flu RNA Vaccines Price (USD/Unit) by Type (2019-2024)
Table 29. Global Flu RNA Vaccines Sales (K Units) by Application
Table 30. Global Flu RNA Vaccines Market Size by Application
Table 31. Global Flu RNA Vaccines Sales by Application (2019-2024) & (K Units)
Table 32. Global Flu RNA Vaccines Sales Market Share by Application (2019-2024)
Table 33. Global Flu RNA Vaccines Sales by Application (2019-2024) & (M USD)
Table 34. Global Flu RNA Vaccines Market Share by Application (2019-2024)
Table 35. Global Flu RNA Vaccines Sales Growth Rate by Application (2019-2024)
Table 36. Global Flu RNA Vaccines Sales by Region (2019-2024) & (K Units)
Table 37. Global Flu RNA Vaccines Sales Market Share by Region (2019-2024)
Table 38. North America Flu RNA Vaccines Sales by Country (2019-2024) & (K Units)
Table 39. Europe Flu RNA Vaccines Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Flu RNA Vaccines Sales by Region (2019-2024) & (K Units)
Table 41. South America Flu RNA Vaccines Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Flu RNA Vaccines Sales by Region (2019-2024) & (K Units)
Table 43. Sanofi Pasteur Inc. Flu RNA Vaccines Basic Information
Table 44. Sanofi Pasteur Inc. Flu RNA Vaccines Product Overview
Table 45. Sanofi Pasteur Inc. Flu RNA Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Sanofi Pasteur Inc. Business Overview
Table 47. Sanofi Pasteur Inc. Flu RNA Vaccines SWOT Analysis
Table 48. Sanofi Pasteur Inc. Recent Developments
Table 49. AstraZeneca Flu RNA Vaccines Basic Information
Table 50. AstraZeneca Flu RNA Vaccines Product Overview
Table 51. AstraZeneca Flu RNA Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Flu RNA Vaccines SWOT Analysis
Table 54. AstraZeneca Recent Developments
Table 55. CSL Ltd. Flu RNA Vaccines Basic Information
Table 56. CSL Ltd. Flu RNA Vaccines Product Overview
Table 57. CSL Ltd. Flu RNA Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. CSL Ltd. Flu RNA Vaccines SWOT Analysis
Table 59. CSL Ltd. Business Overview
Table 60. CSL Ltd. Recent Developments
Table 61. Abbott Flu RNA Vaccines Basic Information
Table 62. Abbott Flu RNA Vaccines Product Overview
Table 63. Abbott Flu RNA Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Abbott Business Overview
Table 65. Abbott Recent Developments
Table 66. GlaxoSmithKline Plc. Flu RNA Vaccines Basic Information
Table 67. GlaxoSmithKline Plc. Flu RNA Vaccines Product Overview
Table 68. GlaxoSmithKline Plc. Flu RNA Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. GlaxoSmithKline Plc. Business Overview
Table 70. GlaxoSmithKline Plc. Recent Developments
Table 71. Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Basic Information
Table 72. Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Product Overview
Table 73. Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Serum Institute of India Pvt. Ltd. Business Overview
Table 75. Serum Institute of India Pvt. Ltd. Recent Developments
Table 76. Pfizer Flu RNA Vaccines Basic Information
Table 77. Pfizer Flu RNA Vaccines Product Overview
Table 78. Pfizer Flu RNA Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Pfizer Business Overview
Table 80. Pfizer Recent Developments
Table 81. BioNTech Flu RNA Vaccines Basic Information
Table 82. BioNTech Flu RNA Vaccines Product Overview
Table 83. BioNTech Flu RNA Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. BioNTech Business Overview
Table 85. BioNTech Recent Developments
Table 86. F.Hoffman La Roche Ltd Flu RNA Vaccines Basic Information
Table 87. F.Hoffman La Roche Ltd Flu RNA Vaccines Product Overview
Table 88. F.Hoffman La Roche Ltd Flu RNA Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. F.Hoffman La Roche Ltd Business Overview
Table 90. F.Hoffman La Roche Ltd Recent Developments
Table 91. Novartis Flu RNA Vaccines Basic Information
Table 92. Novartis Flu RNA Vaccines Product Overview
Table 93. Novartis Flu RNA Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Novartis Business Overview
Table 95. Novartis Recent Developments
Table 96. Sinnovac Biotech Ltd Flu RNA Vaccines Basic Information
Table 97. Sinnovac Biotech Ltd Flu RNA Vaccines Product Overview
Table 98. Sinnovac Biotech Ltd Flu RNA Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Sinnovac Biotech Ltd Business Overview
Table 100. Sinnovac Biotech Ltd Recent Developments
Table 101. Moderna Therapeutics Flu RNA Vaccines Basic Information
Table 102. Moderna Therapeutics Flu RNA Vaccines Product Overview
Table 103. Moderna Therapeutics Flu RNA Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Moderna Therapeutics Business Overview
Table 105. Moderna Therapeutics Recent Developments
Table 106. CureVac Flu RNA Vaccines Basic Information
Table 107. CureVac Flu RNA Vaccines Product Overview
Table 108. CureVac Flu RNA Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. CureVac Business Overview
Table 110. CureVac Recent Developments
Table 111. Global Flu RNA Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Flu RNA Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Flu RNA Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Flu RNA Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Flu RNA Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Flu RNA Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Flu RNA Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Flu RNA Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Flu RNA Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Flu RNA Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Flu RNA Vaccines Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Flu RNA Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Flu RNA Vaccines Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Flu RNA Vaccines Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Flu RNA Vaccines Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Flu RNA Vaccines Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Flu RNA Vaccines Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Flu RNA Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Flu RNA Vaccines Market Size (M USD), 2019-2030
Figure 5. Global Flu RNA Vaccines Market Size (M USD) (2019-2030)
Figure 6. Global Flu RNA Vaccines Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Flu RNA Vaccines Market Size by Country (M USD)
Figure 11. Flu RNA Vaccines Sales Share by Manufacturers in 2023
Figure 12. Global Flu RNA Vaccines Revenue Share by Manufacturers in 2023
Figure 13. Flu RNA Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Flu RNA Vaccines Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Flu RNA Vaccines Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Flu RNA Vaccines Market Share by Type
Figure 18. Sales Market Share of Flu RNA Vaccines by Type (2019-2024)
Figure 19. Sales Market Share of Flu RNA Vaccines by Type in 2023
Figure 20. Market Size Share of Flu RNA Vaccines by Type (2019-2024)
Figure 21. Market Size Market Share of Flu RNA Vaccines by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Flu RNA Vaccines Market Share by Application
Figure 24. Global Flu RNA Vaccines Sales Market Share by Application (2019-2024)
Figure 25. Global Flu RNA Vaccines Sales Market Share by Application in 2023
Figure 26. Global Flu RNA Vaccines Market Share by Application (2019-2024)
Figure 27. Global Flu RNA Vaccines Market Share by Application in 2023
Figure 28. Global Flu RNA Vaccines Sales Growth Rate by Application (2019-2024)
Figure 29. Global Flu RNA Vaccines Sales Market Share by Region (2019-2024)
Figure 30. North America Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Flu RNA Vaccines Sales Market Share by Country in 2023
Figure 32. U.S. Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Flu RNA Vaccines Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Flu RNA Vaccines Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Flu RNA Vaccines Sales Market Share by Country in 2023
Figure 37. Germany Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Flu RNA Vaccines Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Flu RNA Vaccines Sales Market Share by Region in 2023
Figure 44. China Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Flu RNA Vaccines Sales and Growth Rate (K Units)
Figure 50. South America Flu RNA Vaccines Sales Market Share by Country in 2023
Figure 51. Brazil Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Flu RNA Vaccines Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Flu RNA Vaccines Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Flu RNA Vaccines Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Flu RNA Vaccines Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Flu RNA Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Flu RNA Vaccines Market Share Forecast by Type (2025-2030)
Figure 65. Global Flu RNA Vaccines Sales Forecast by Application (2025-2030)
Figure 66. Global Flu RNA Vaccines Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Flu RNA Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Flu RNA Vaccines Market Size (M USD), 2019-2030
Figure 5. Global Flu RNA Vaccines Market Size (M USD) (2019-2030)
Figure 6. Global Flu RNA Vaccines Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Flu RNA Vaccines Market Size by Country (M USD)
Figure 11. Flu RNA Vaccines Sales Share by Manufacturers in 2023
Figure 12. Global Flu RNA Vaccines Revenue Share by Manufacturers in 2023
Figure 13. Flu RNA Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Flu RNA Vaccines Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Flu RNA Vaccines Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Flu RNA Vaccines Market Share by Type
Figure 18. Sales Market Share of Flu RNA Vaccines by Type (2019-2024)
Figure 19. Sales Market Share of Flu RNA Vaccines by Type in 2023
Figure 20. Market Size Share of Flu RNA Vaccines by Type (2019-2024)
Figure 21. Market Size Market Share of Flu RNA Vaccines by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Flu RNA Vaccines Market Share by Application
Figure 24. Global Flu RNA Vaccines Sales Market Share by Application (2019-2024)
Figure 25. Global Flu RNA Vaccines Sales Market Share by Application in 2023
Figure 26. Global Flu RNA Vaccines Market Share by Application (2019-2024)
Figure 27. Global Flu RNA Vaccines Market Share by Application in 2023
Figure 28. Global Flu RNA Vaccines Sales Growth Rate by Application (2019-2024)
Figure 29. Global Flu RNA Vaccines Sales Market Share by Region (2019-2024)
Figure 30. North America Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Flu RNA Vaccines Sales Market Share by Country in 2023
Figure 32. U.S. Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Flu RNA Vaccines Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Flu RNA Vaccines Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Flu RNA Vaccines Sales Market Share by Country in 2023
Figure 37. Germany Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Flu RNA Vaccines Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Flu RNA Vaccines Sales Market Share by Region in 2023
Figure 44. China Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Flu RNA Vaccines Sales and Growth Rate (K Units)
Figure 50. South America Flu RNA Vaccines Sales Market Share by Country in 2023
Figure 51. Brazil Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Flu RNA Vaccines Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Flu RNA Vaccines Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Flu RNA Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Flu RNA Vaccines Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Flu RNA Vaccines Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Flu RNA Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Flu RNA Vaccines Market Share Forecast by Type (2025-2030)
Figure 65. Global Flu RNA Vaccines Sales Forecast by Application (2025-2030)
Figure 66. Global Flu RNA Vaccines Market Share Forecast by Application (2025-2030)
